dan 2163 has been researched along with palmidrol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gerth, CW; Hellmich, M; Hoyer, C; Klosterkötter, J; Koethe, D; Leweke, FM; Muhl, D; Pahlisch, F; Piomelli, D | 1 |
1 trial(s) available for dan 2163 and palmidrol
Article | Year |
---|---|
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
Topics: Acute Disease; Adult; Amides; Amisulpride; Antipsychotic Agents; Arachidonic Acids; Cannabidiol; Double-Blind Method; Drug Therapy, Combination; Endocannabinoids; Ethanolamines; Female; Humans; Male; Oleic Acids; Palmitic Acids; Polyunsaturated Alkamides; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Signal Transduction; Sulpiride; Young Adult | 2012 |